Comparison of thiazides and amiloride in treatment of moderate hypertension
- PMID: 6409208
- PMCID: PMC1548476
- DOI: 10.1136/bmj.286.6383.2015
Comparison of thiazides and amiloride in treatment of moderate hypertension
Abstract
The biochemical disturbance produced by thiazide diuretics and by amiloride during treatment of moderate hypertension were compared. Two parallel studies were initiated. In one 40 patients with newly diagnosed hypertension were treated with metoprolol and a diuretic, either hydrochlorothiazide or amiloride. In a second study 38 patients receiving longstanding treatment with hypotensives and thiazides either continued the treatment or replaced the thiazide with amiloride. Initial biochemical assessments were compared with those after two years in the study. In previously untreated patients, thiazide produced a significant fall in plasma potassium and hyperuricaemia that did not occur with amiloride (p less than 0.001). Those patients receiving long term treatment for their hypertension who continued to take thiazides had persistent hypokalaemia and hyperuricaemia. Substitution with amiloride corrected the hypokalaemia and serum uric acid returned toward normal ranges, but this change was not statistically significant. Patients receiving long term treatment also had impaired glucose tolerance, this remained unchanged in those receiving thiazide but was corrected in those receiving amiloride. Compared with amiloride thiazides produced undesirable but reversible biochemical changes. As control of hypertension was equally effective with both preparations, we suggest that a combination of amiloride with a beta blocker in treatment of moderate hypertension in preferred.
Similar articles
-
Amiloride: A review.J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320975893. doi: 10.1177/1470320320975893. J Renin Angiotensin Aldosterone Syst. 2020. PMID: 33234024 Free PMC article. Review.
-
Potassium conservation with amiloride/hydrochlorothiazide ("Moduret') in thiazide-induced hypokalaemia in hypertension.Curr Med Res Opin. 1982;8(2):120-7. doi: 10.1185/03007998209109767. Curr Med Res Opin. 1982. PMID: 7049587 Clinical Trial.
-
[Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].Clin Ter. 1978 Oct 15;87(1):69-74. Clin Ter. 1978. PMID: 737980 Italian. No abstract available.
-
Plasma potassium levels in hypertensive patients receiving fixed-combination diuretic therapy.Med J Aust. 1980 Apr 19;1(8):376-8. doi: 10.5694/j.1326-5377.1980.tb134930.x. Med J Aust. 1980. PMID: 7393077
-
[Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone].Minerva Med. 1978 Jun 23;69(31):2115-23. Minerva Med. 1978. PMID: 351464 Review. Italian. No abstract available.
Cited by
-
Amiloride: A review.J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320975893. doi: 10.1177/1470320320975893. J Renin Angiotensin Aldosterone Syst. 2020. PMID: 33234024 Free PMC article. Review.
-
Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives.J Clin Hypertens (Greenwich). 2014 Jan;16(1):47-53. doi: 10.1111/jch.12218. Epub 2013 Oct 31. J Clin Hypertens (Greenwich). 2014. PMID: 24410943 Free PMC article. Clinical Trial.
-
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.Lancet Diabetes Endocrinol. 2016 Feb;4(2):136-47. doi: 10.1016/S2213-8587(15)00377-0. Epub 2015 Oct 18. Lancet Diabetes Endocrinol. 2016. PMID: 26489809 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials